Safety and Efficacy of 333369 in the Treatment of Partial Epilepsy

Effectiveness and Safety Study for RWJ-333369 as Adjunctive Therapy in Korean and Japanese Patients With Partial Onset Seizures

NCT00697762 ·Status: TERMINATED ·Phase: PHASE3

An Open-Label Extension Study to Evaluate the Safety and Tolerability of RWJ 333369 as Adjunctive Therapy in Patients 16 Years and Older With Partial Onset Seizures.

NCT00991757 ·Status: COMPLETED ·Phase: PHASE3

Retigabine (Adjunctive Therapy) Efficacy and Safety Study for Partial Onset Refractory Seizures in Epilepsy

NCT00232596 ·Status: COMPLETED ·Phase: PHASE3

A Study of the Effectiveness and Safety of Topiramate Monotherapy in Patients With Recently Diagnosed Partial-Onset Seizure

NCT00230698 ·Status: COMPLETED ·Phase: PHASE3

Retigabine Efficacy and Safety Trial for Partial Onset Refractory Seizures in Epilepsy

NCT00235755 ·Status: COMPLETED ·Phase: PHASE3

Open-label Extension Study of the Phase 3 VRX-RET-E22-301 Double-Blind Trial

NCT00310375 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) Seizures

NCT05067634 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Open-Label Extension Study of the Phase 3 VRX-RET-E22-302 Double-Blind Trial. 115097

NCT00310388 ·Status: TERMINATED ·Phase: PHASE3

A Study to Look at the Efficacy and Safety of Keppra® Extended Release Formulation - XR

NCT00368069 ·Status: COMPLETED ·Phase: PHASE3

A Study of the Efficacy and Safety of Topiramate in the Treatment of Patients With Epilepsy.

NCT00236847 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures

NCT01397968 ·Status: COMPLETED ·Phase: PHASE2

A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures

NCT00236860 ·Status: COMPLETED ·Phase: PHASE2

Study Of The Safety And Efficacy Of Lyrica In The Treatment Of Newly Diagnosed Partial Epilepsy

NCT00280059 ·Status: COMPLETED ·Phase: PHASE3

A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.

NCT00236691 ·Status: COMPLETED ·Phase: PHASE2

Safety and Pharmacokinetic Study of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures

NCT02535091 ·Status: COMPLETED ·Phase: PHASE3

Study in Pediatric Subjects With Epilepsy

NCT01494584 ·Status: TERMINATED ·Phase: PHASE2

Repeat Dose Safety Study of NRL-1 in Epilepsy Subjects

NCT02721069 ·Status: COMPLETED ·Phase: PHASE3

Efficacy of YKP3089 in Patients With Photosensitive Epilepsy

NCT00616148 ·Status: COMPLETED ·Phase: PHASE2

Dose-Escalation Study of Cenobamate (YKP3089) in Pediatric Subjects With Partial-Onset Seizures

NCT04903314 ·Status: COMPLETED ·Phase: PHASE1

A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures

NCT07219407 ·Status: RECRUITING ·Phase: PHASE2

Study of Retigabine Immediate Release as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults With Partial-Onset Seizures

NCT01227902 ·Status: COMPLETED ·Phase: PHASE3

A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.

NCT00236873 ·Status: COMPLETED ·Phase: PHASE2

Open-label Study of Cenobamate Monotherapy in Adult Subjects With Newly Diagnosed or Recurrent Partial-Onset Epilepsy

NCT06453213 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

A Pediatric Drug Study to Determine the Long-term Safety and Tolerability in Children and Adolescents (4-17 Years in Age) Taking the Drug

NCT03108729 ·Status: WITHDRAWN ·Phase: PHASE3

Comparative Study of Dietary and Immunological Management of Refractory Epilepsy in Children

NCT04542629 ·Status: UNKNOWN ·Phase: PHASE4